LRP1B and head and neck squamous cell carcinoma: Secondly, the biomarker role of LRP1B in ICIs was showed in other cancer types, there was no ICIs treatment cohort of CC or HNSCC included for clinical analysis, making the biomarker role of LRP1B only focus on cancer survival, mutation count, AUC analysis, and molecular bases of CC and HNSCC.